We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-13.1%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$5B
AUM Growth
-$909M
Cap. Flow
-$36.2M
Cap. Flow %
-0.72%
Top 10 Hldgs %
18.91%
Holding
2,646
New
66
Increased
797
Reduced
791
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Financials 13.9%
3 Healthcare 13.55%
4 Consumer Discretionary 10%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
76
Biogen
BIIB
$30.9B
$11.7M 0.23%
38,979
-93
-0.2% -$29.7K
CI icon
77
Cigna
CI
$73.3B
$11.4M 0.23%
60,044
+20,453
+52% +$4.27M
ADP icon
78
Automatic Data Processing
ADP
$107B
$11.2M 0.22%
85,572
-433
-0.5% -$61.1K
TJX icon
79
TJX Companies
TJX
$169B
$10.8M 0.22%
241,344
-6,326
-3% -$320K
ISRG icon
80
Intuitive Surgical
ISRG
$142B
$10.6M 0.21%
66,384
-141
-0.2% -$23.9K
COP icon
81
ConocoPhillips
COP
$153B
$10.2M 0.2%
164,121
-5,616
-3% -$382K
CME icon
82
CME Group
CME
$94.3B
$10.2M 0.2%
54,059
+3,436
+7% +$635K
QCOM icon
83
Qualcomm
QCOM
$171B
$9.92M 0.2%
174,398
-31,214
-15% -$1.9M
SYK icon
84
Stryker
SYK
$133B
$9.92M 0.2%
63,302
+87
+0.1% +$14.6K
USB icon
85
US Bancorp
USB
$101B
$9.89M 0.2%
216,385
-7,148
-3% -$368K
ELV icon
86
Elevance Health
ELV
$86.6B
$9.88M 0.2%
37,623
+92
+0.2% +$25.3K
SCHW
87
Charles Schwab
SCHW
$189B
$9.8M 0.2%
235,919
+460
+0.2% +$20.8K
INTU icon
88
Intuit
INTU
$91.6B
$9.72M 0.19%
49,398
-126
-0.3% -$26.2K
GE icon
89
GE Aerospace
GE
$379B
$9.55M 0.19%
263,344
-846
-0.3% -$38.2K
DE icon
90
Deere & Co
DE
$167B
$9.51M 0.19%
63,767
+188
+0.3% +$27.5K
DHR icon
91
Danaher
DHR
$145B
$9.15M 0.18%
100,056
-1,333
-1% -$121K
CHTR icon
92
Charter Communications
CHTR
$17.9B
$9.07M 0.18%
31,824
-124
-0.4% -$38.9K
BDX icon
93
Becton Dickinson
BDX
$50B
$8.94M 0.18%
40,687
+228
+0.6% +$52.9K
DUK icon
94
Duke Energy
DUK
$96.3B
$8.94M 0.18%
103,594
-337
-0.3% -$28.7K
BSX icon
95
Boston Scientific
BSX
$74.5B
$8.93M 0.18%
252,679
-992
-0.4% -$36K
CELG
96
DELISTED
Celgene Corp
CELG
$8.82M 0.18%
137,574
-87
-0.1% -$6.42K
CB icon
97
Chubb
CB
$132B
$8.64M 0.17%
66,904
-678
-1% -$87.6K
RTN
98
DELISTED
Raytheon Company
RTN
$8.61M 0.17%
56,144
-207
-0.4% -$37.1K
ILMN icon
99
Illumina
ILMN
$29.1B
$8.59M 0.17%
29,442
-136
-0.5% -$42.1K
MDLZ icon
100
Mondelez International
MDLZ
$79.4B
$8.43M 0.17%
210,609
-2,878
-1% -$123K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 Portfolio in Review

As of Q4 2018, Metropolitan Life Insurance Company (MetLife) held 2,646 positions worth $5B, down 15% from $5.91B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2018 filing shows 66 new, 797 increased, 791 reduced and 99 closed positions. Its largest new stake was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M. The largest sale was Aetna Inc, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 58,446 shares worth $1.17M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $61M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $10.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Aetna Inc in Q4 2018, selling an estimated $10.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5B portfolio in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 99 in Q4 2018.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 15% quarter-over-quarter to $5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.